Registration of Tobacco, Coffee and Substance Use Among Acutely Admitted Psychiatric Patients
NCT ID: NCT00184184
Last Updated: 2017-03-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
262 participants
OBSERVATIONAL
2004-10-31
2005-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Norwegian Addiction, Pain and Trauma Study
NCT04908410
Voluntary Drug Poisoning by Psychoactive Molecules: Identify Cognitive Markers
NCT03481192
Psychoactive Drug Uses Among Medical and Pharmacy Students
NCT05115981
Examining Expectancy Challenges to Prevent Nonmedical Prescription Stimulant Use
NCT03648684
Psychiatric Disorders in Addiction - Interest of Screening and Influence on Relapse
NCT07023419
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
We will also compare results of substance in immunologic rapid urine tests taken by the nurse at the hospital with substance in urine tested in laboratory with LC/MS (liquid chromatography/mass spectrometry).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Serious brain damage
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
St. Olavs Hospital
OTHER
Norwegian University of Science and Technology
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gunnar Morken, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Norwegian ministry of Education and Research
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Østmarka Psychiatric Department, St. Olavs Hospital, University Hospital of Trondheim
Trondheim, , Norway
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Bagoien G, Morken G, Zahlsen K, Aamo T, Spigset O. Evaluation of a urine on-site drugs of abuse screening test in patients admitted to a psychiatric emergency unit. J Clin Psychopharmacol. 2009 Jun;29(3):248-54. doi: 10.1097/JCP.0b013e3181a45e78.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GB- TKR 2004
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.